NEOGENOMICS INC — Director's Dealing 2020

Jun 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-05-28

Reporting Person: HANNAH ALISON L. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-28	Common Stock	A	2698	—	Acquired	78796	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-28	Stock Options (Right to Buy)	$28.54	A	3448	Acquired	2027-05-28	Common Stock (3448.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.27	2022-05-25	Common Stock (10000.0)	10000	Direct
Stock Option (Right to Buy)	$11.6	2023-06-01	Common Stock (3017.0)	3017	Direct
Stock Options (Right to Buy)	$22.52	2026-06-06	Common Stock (4269.0)	4269	Direct

Footnotes

F1: On May 25, 2017, Ms. Hannah was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.